Status: current, Defined. Date: 31-Jan 2019. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3206751000168114 | hyaluronate sodium 800 mg / 50 mL + sodium chondroitin sulfate 1 g / 50 mL injection, 50 mL syringe (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3206761000168111 | hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe | Is a | hyaluronic acid + chondroitin sulfate | true | Inferred relationship | Some | ||
hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe | has unit of use | syringe | true | Inferred relationship | Some | 1840837327 | |
hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe | has Australian BoSS | hyaluronate sodium | true | Inferred relationship | Some | 1840837326 | |
hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe | has intended active ingredient | hyaluronic acid | true | Inferred relationship | Some | 1840837326 | |
hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe | has Australian BoSS | sodium chondroitin sulfate | true | Inferred relationship | Some | 687711292 | |
hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe | has intended active ingredient | chondroitin sulfate | true | Inferred relationship | Some | 687711292 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, 50 mL syringe | has MPUU | True | hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe | Inferred relationship | Some | 1 |
Ialuril injection, 50 mL syringe | Is a | True | hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set